Clarifies on News item
With reference to the news reported in Business Line, 16/09/2015, "Orchid Pharmaceuticals in talks with banks to rejig debt", Orchid Chemicals & Pharmaceuticals Ltd has Clarified to BSE as under:"The company is currently in talks with banks to explore the possibility of converting its rupee debt into dollar denominated debt. This plan is to try and reduce the interest burden on the company which will ultimately be beneficial to the company's bottom line.... Orchid Pharmaceuticals in talks with banks to rejig debt
Hopes to break even with new product launches Clarification sought from Orchid Chemicals & Pharmaceuticals Ltd
The Exchange has sought clarification from Orchid Chemicals & Pharmaceuticals Ltd with reference to the news reported in Business Line, 16/09/2015, "Orchid Pharmaceuticals in talks with banks to rejig debt"The reply is awaited. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
K Raghavenra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE AGM on Sept 15, 2015
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the 22nd Annual General Meeting (AGM) of the Company will be held on September 15, 2015. Fixes Book Closure for AGM
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 11, 2015 to September 15, 2015 (both days inclusive) for the purpose of 22nd Annual General Meeting (AGM) of the Company to be held on September 15, 2015 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
SBICAP Trustee Company Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 Orchid Chemicals & Pharmaceuticals Q1 net loss at Rs 48 cr
Drug firm Orchid Chemicals & Pharmaceuticals today reported a standalone net loss of Rs 47.56 crore for the quarter ended June 30, 2015. The company had posted a net loss of Rs 60.14 crore for the corresponding period of the previous fiscal, ... Financial Results with Results Press Release & Limited Review Report for June 30, 2015 (Standalone)
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE about the Standalone Financial Results, Results Press Release & a copy of the Limited Review Report for the period ended June 30, 2015.